(ARQT) Arcutis - Performance 46.7% in 12m
ARQT performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-37.90%
#54 in Peer-Group
Rel. Strength
83.91%
#1194 in Stock-Universe
Total Return 12m
46.65%
#25 in Peer-Group
Total Return 5y
-56.20%
#64 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 17.29 USD |
| 52 Week Low | 8.31 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 52.80 |
| Buy/Sell Signal +-5 | 0.95 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ARQT (46.7%) vs XBI (-10.8%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
2.52% | 66.7% | 77.4% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-11.7% | -9.92% | 139% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-3.21% | -7.33% | 26.4% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
-0.28% | 31.9% | -4.56% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
0.91% | -10.3% | 0.26% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.3% | 65.1% | -9.72% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
0.02% | 56.7% | -7.85% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
2.86% | 34.5% | 14.3% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: ARQT vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ARQT
| Total Return (including Dividends) | ARQT | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 4.01% | 2.09% | 4.55% |
| 3 Months | -10.36% | 2.27% | 10.78% |
| 12 Months | 46.65% | -10.84% | 14.71% |
| 5 Years | -56.20% | -26.24% | 112.53% |
| Trend Score (consistency of price movement) | ARQT | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 58% | 18.8% | 79.2% |
| 3 Months | -21.8% | 71.5% | 92.9% |
| 12 Months | 77% | -84.3% | 44.2% |
| 5 Years | -80% | -52.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th67.00 | 1.88% | -0.52% |
| 3 Month | %th37.50 | -12.34% | -19.08% |
| 12 Month | %th87.50 | 64.48% | 27.85% |
| 5 Years | %th67.50 | -40.62% | -79.39% |
FAQs
Does Arcutis (ARQT) outperform the market?
Yes,
over the last 12 months ARQT made 46.65%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.84%.
Over the last 3 months ARQT made -10.36%, while XBI made 2.27%.
Performance Comparison ARQT vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ARQT vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -5.6% | -0.5% | -5.4% | 32% |
| US NASDAQ 100 | QQQ | -6.4% | -1.5% | -7.5% | 32% |
| German DAX 40 | DAX | -5.4% | 4% | -18.3% | 17% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -5.3% | -0.2% | -3.4% | 29% |
| Hongkong Hang Seng | HSI | -5.2% | -1.8% | -21.1% | 11% |
| India NIFTY 50 | INDA | -5.2% | 1.9% | -5.1% | 47% |
| Brasil Bovespa | EWZ | -6.9% | -3.8% | -29.9% | 33% |
ARQT vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -7.1% | -2.8% | -12.1% | 18% |
| Consumer Discretionary | XLY | -4% | 2.4% | 3.3% | 27% |
| Consumer Staples | XLP | -2.1% | 5.6% | -3.6% | 37% |
| Energy | XLE | -1.2% | 0.5% | 0.1% | 51% |
| Financial | XLF | -5.7% | 0.9% | -8.5% | 18% |
| Health Care | XLV | -4.6% | 2% | 1.8% | 52% |
| Industrial | XLI | -5.2% | 0.3% | -12% | 23% |
| Materials | XLB | -3.6% | 2.4% | -4.7% | 44% |
| Real Estate | XLRE | -1.1% | 4% | -2.8% | 34% |
| Technology | XLK | -6.9% | -4.9% | -8.6% | 35% |
| Utilities | XLU | -3.2% | 4% | -8.8% | 22% |
| Aerospace & Defense | XAR | -7.5% | -5.9% | -26.8% | -6% |
| Biotech | XBI | -3.4% | 1.9% | 8.6% | 57% |
| Homebuilder | XHB | -3.8% | -2.1% | 5.9% | 46% |
| Retail | XRT | -2.5% | 2.6% | 3.3% | 40% |
ARQT vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 1.7% | -1.11% | 3.88% | 57% |
| Natural Gas | UNG | 6.6% | 13.4% | 9.8% | 54% |
| Gold | GLD | -0.6% | 6.2% | -25.3% | 5% |
| Silver | SLV | -2.2% | 0.2% | -24% | 24% |
| Copper | CPER | -5.9% | -0.2% | -25.1% | 31% |
ARQT vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -4.4% | 0.4% | -2.2% | 45% |
| iShares High Yield Corp. Bond | HYG | -3.5% | 2.2% | -4.4% | 36% |